Stock Market News for August 24, 2026

Market-moving corporate finance and strategic deals

USA Rare Earth (USAR) completed an upsized $1.55 billion capitalization of a U.S. government‑backed SPV tied to the Serra Verde offtake. The filing underscores federal support for critical‑minerals supply chains and could re‑rate rare‑earth and defense suppliers.

Lithium Argentina (LAR) closed its PPG joint venture and secured a $180 million strategic investment from Ganfeng. Project financing helps de‑risk battery‑grade lithium output amid fierce EV supply‑chain competition.

Nebius Group (NBIS) closed a private offering of convertible senior notes raising roughly $5.75 billion. Large financing materially reshapes capital structure and investors will watch dilution terms and use of proceeds.

Arbutus (ABUS) launched a US$230 million modified Dutch‑auction tender offer, pricing between US$5.00–US$5.75. Buybacks can tighten float and support near‑term share dynamics.

The Metals Royalty Company (TMC) closed on an additional 1.0% Mesabi royalty and secured US$165 million in financing. Royalty financing provides capital to back portfolio royalties and signals ongoing investor appetite for streaming and royalty models.

Energy, storage, crypto mining and balance‑sheet crypto

TeraWulf (WULF) won Kentucky PSC approval for a 482 MW power agreement for its Justified Data campus. Long‑term capacity deals remain critical where power is the binding constraint for miners and compute hubs.

BTC Digital (BTCT) said a 10MW Georgia cryptocurrency computing site is nearing deployment readiness. New deployments highlight continued North American mining buildout.

Zerostack Corp. (ZSTK) reported cryptocurrency holdings with an aggregate market value of approximately $1.06 billion. Balance‑sheet crypto disclosures can swing valuation multiples for fintechs and crypto‑native platforms.

Consumer, retail, digital collectibles and real estate deals

Real and RE/MAX Holdings (REAX) announced completion of their business combination and followed with a $450 million share repurchase authorization. The combination plus the buyback is a clear capital‑allocation signal aimed at boosting EPS and shareholder returns.

Orangekloud Technology (ORKT) agreed to acquire Orbis Technology Limited, operator of the VeVe digital collectibles platform. The acquisition widens consumer engagement in NFTs and digital goods, melding e‑commerce with collectible ecosystems.

Urban Story Ventures (VENU) unveiled a $350 million retail and residential district in Bend alongside a separate $300 million amphitheater project. Large‑scale development can create long‑term cash flows for RE developers and local economies.

Technology, AI infrastructure, robotics and quantum

ZJK (ZJK) secured large‑volume purchase orders for AI infrastructure components. Order flow offers an early signal of enterprise AI capex strength for chip‑adjacent suppliers.

Infleqtion (INFQ) and Japan’s Moonshot program reported the “Shunkai” neutral‑atom quantum computer is operational. Operational hardware is a milestone for cloud quantum services roadmaps and potential customer contracts.

IonQ (IONQ) said Skyloom optical communications terminals now total 84 on‑orbit installations after the latest launch. Scaling space links matters for quantum networking and satellite comms strategies.

Micropolis Robotics (MCRP) became a robotics and physical‑AI solutions provider to ADNOC. The partnership spotlights industrial automation demand in energy and logistics, and validates robotics-as-a-service in heavy‑industry rollouts.

Index moves, mining and materials

Evolution Metals & Technologies (EMAT) announced preliminary inclusion in the Russell 3000® and Russell 2000® indexes. Index additions often prompt passive inflows and improved liquidity.

Greenland Mines (GRML) delivered an S‑K 1300 resource estimate for Sarfartoq, including the project's first indicated resource for Nd‑Pr magnet rare earths. Resource milestones can accelerate project financing and buyer interest from magnet manufacturers.

Silver Bow Mining (SBMT) agreed to acquire the Jefferson County Metallurgical Complex. M&A can lift margins through processing synergies and shorten concentrate‑to‑product timelines.

Capital markets, earnings and corporate milestones

Gogoro (GGR) released Q2 results and announced a CFO retirement alongside appointment of a principal financial officer. Earnings and leadership moves can affect guidance credibility and investor sentiment.

The9 (NCTY) posted US$32 million net income for Q2 2026, up >39% sequentially. Profit beats often attract momentum interest in turnaround names.

Gorilla Technology (GRRR) reported H1 revenue surged 99% to US$78.4 million and raised FY2026 revenue outlook to at least US$200 million. Upgraded guidance is a clear growth signal for enterprise AI and video‑analytics vendors; watch margins and backlog conversion.

PicPay (PICS) released second‑quarter 2026 results. Latin America fintech earnings offer insight into payments traction and margin recovery in a key regional market.

WeShop (WSHP) posted first‑half 2026 financial results on its website. H1 disclosures help reset investor expectations for growth and path to profitability.

Faraday Future (FFAI) eliminated 237,615 potential warrants as part of ongoing capital‑structure optimization to support its robotics strategy. Warrant removals can reduce overhang and reflect a shift toward strategic priorities beyond core EV manufacturing.

Teradyne (TER) declared a quarterly cash dividend. Dividend moves may attract income‑focused shareholders and signal confidence in free cash flow for test‑equipment makers.

Biotech, regulatory moves and clinical milestones

Tempus (TEM) received FDA clearance for an AI product to detect pulmonary hypertension from standard ECGs. Regulatory clearance is a commercial inflection for AI diagnostics and could accelerate payer conversations and enterprise adoption.

Capricor Therapeutics (CAPR) announced an extension of the PDUFA target action date for the Deramiocel BLA. Timing shifts compress near‑term upside and force investors to reprice catalyst calendars.

Savara (SVRA) will present encore Phase 3 molgramostim results at ERS 2026. Late‑stage data presentations can reignite investor focus if they clarify efficacy or safety signals.

Selected smaller but material updates

• GRI Bio (GRI) will present late‑breaking Phase 2a data at ERS 2026 on lung function and anti‑fibrotic biomarkers. Potential readouts matter for small‑cap biotech re‑rating.

• BioCardia (BCDA) said the FDA confirmed meeting minutes for its Helix delivery catheter, supporting a De Novo pre‑submission. Regulatory alignment can shorten time to market.

• Monte Rosa Therapeutics (GLUE) dosed the first patient in a Phase 2 mCRPC combination trial. Clinical starts reduce key development uncertainty.